Any focus on the cost of treatment is incredibly misguided when it comes to personalised medicines because it belies the reality of what they will provide - governments will be paying for less failure and the potential for cures will mean patients will be treated with fewer therapies. …
What happens when the government is paying for less failure?
August 7, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
Retail leader's surprise at the size of revenue revealed by Chemist Warehouse
April 17, 2024 - - Latest News -
Longstanding health sector leader and advocate steps down after 24 years
April 17, 2024 - - Latest News -
'We celebrate our 60th anniversary in Australia, I am extremely optimistic about the next 60'
April 17, 2024 - - Latest News -
Ex-AusBiotech CEO appointed to lead peak body for manufacturing technology sector
April 16, 2024 - - Latest News -
Plan recommends greater 'transparency and accountability of health procurement processes'
April 16, 2024 - - Latest News -
HTA review extended by three weeks following reference committee request
April 16, 2024 - - Latest News -
Gilead celebrates 25 years in Australia and NZ with official office opening
April 16, 2024 - - Latest News